Paul Rozance
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sheep | 74 | 2025 | 832 | 8.050 |
Why?
| Hypoglycemia | 29 | 2024 | 427 | 7.540 |
Why?
| Glucose | 47 | 2024 | 976 | 7.430 |
Why?
| Fetus | 47 | 2025 | 764 | 7.320 |
Why?
| Fetal Growth Retardation | 54 | 2024 | 542 | 7.140 |
Why?
| Insulin | 45 | 2025 | 2311 | 5.580 |
Why?
| Placental Insufficiency | 21 | 2024 | 111 | 5.110 |
Why?
| Amino Acids | 20 | 2025 | 469 | 3.870 |
Why?
| Blood Glucose | 34 | 2025 | 2086 | 3.850 |
Why?
| Islets of Langerhans | 13 | 2024 | 792 | 3.580 |
Why?
| Insulin-Secreting Cells | 14 | 2024 | 363 | 3.520 |
Why?
| Pregnancy | 89 | 2025 | 6247 | 3.230 |
Why?
| Insulin-Like Growth Factor I | 9 | 2024 | 308 | 3.140 |
Why?
| Placenta | 16 | 2025 | 706 | 3.000 |
Why?
| Glucagon | 10 | 2025 | 105 | 2.800 |
Why?
| Liver | 20 | 2025 | 1832 | 2.600 |
Why?
| Fetal Development | 17 | 2024 | 283 | 2.590 |
Why?
| Pancreas | 14 | 2024 | 307 | 2.360 |
Why?
| Hyperinsulinism | 7 | 2020 | 119 | 2.150 |
Why?
| Leucine | 8 | 2022 | 106 | 2.090 |
Why?
| Hyperglycemia | 7 | 2021 | 321 | 2.020 |
Why?
| Infant, Premature | 8 | 2024 | 540 | 1.820 |
Why?
| Infant, Newborn, Diseases | 5 | 2019 | 108 | 1.790 |
Why?
| Maternal-Fetal Exchange | 7 | 2024 | 159 | 1.610 |
Why?
| Animals | 87 | 2025 | 34628 | 1.590 |
Why?
| Fetal Blood | 10 | 2024 | 315 | 1.410 |
Why?
| Muscle, Skeletal | 15 | 2022 | 1629 | 1.370 |
Why?
| Myoblasts | 3 | 2021 | 76 | 1.340 |
Why?
| Infant, Newborn | 25 | 2024 | 5704 | 1.330 |
Why?
| Female | 100 | 2025 | 68162 | 1.310 |
Why?
| Intensive Care Units, Neonatal | 2 | 2024 | 226 | 1.230 |
Why?
| Monitoring, Physiologic | 3 | 2018 | 265 | 1.210 |
Why?
| Cell Proliferation | 6 | 2024 | 2337 | 1.210 |
Why?
| Fetal Hypoxia | 3 | 2021 | 51 | 1.200 |
Why?
| Hypoxia | 6 | 2021 | 1070 | 1.200 |
Why?
| Gestational Age | 14 | 2021 | 857 | 1.160 |
Why?
| Gluconeogenesis | 8 | 2025 | 73 | 1.030 |
Why?
| Placental Lactogen | 6 | 2024 | 24 | 1.020 |
Why?
| Glucagon-Secreting Cells | 2 | 2024 | 24 | 1.010 |
Why?
| Hepatocyte Growth Factor | 2 | 2016 | 34 | 0.980 |
Why?
| Hypoglycemic Agents | 7 | 2024 | 1206 | 0.880 |
Why?
| Metformin | 2 | 2024 | 307 | 0.860 |
Why?
| Diabetes, Gestational | 3 | 2022 | 306 | 0.800 |
Why?
| Hindlimb | 3 | 2021 | 126 | 0.770 |
Why?
| Streptozocin | 1 | 2021 | 16 | 0.740 |
Why?
| Signal Transduction | 9 | 2021 | 4857 | 0.730 |
Why?
| Muscle Proteins | 3 | 2022 | 224 | 0.730 |
Why?
| NF-kappa B | 2 | 2021 | 685 | 0.690 |
Why?
| Caloric Restriction | 2 | 2024 | 108 | 0.680 |
Why?
| Oxygen | 13 | 2024 | 912 | 0.660 |
Why?
| RNA Interference | 5 | 2024 | 448 | 0.630 |
Why?
| Infant, Very Low Birth Weight | 1 | 2018 | 68 | 0.600 |
Why?
| Anemia | 2 | 2017 | 155 | 0.590 |
Why?
| Catecholamines | 2 | 2017 | 96 | 0.560 |
Why?
| Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2016 | 31 | 0.560 |
Why?
| Surface-Active Agents | 1 | 2017 | 82 | 0.550 |
Why?
| Protein Biosynthesis | 3 | 2017 | 409 | 0.530 |
Why?
| Water Deprivation | 1 | 2016 | 8 | 0.520 |
Why?
| Respiratory System | 1 | 2017 | 153 | 0.520 |
Why?
| Nutritional Physiological Phenomena | 1 | 2016 | 52 | 0.510 |
Why?
| RNA, Messenger | 7 | 2022 | 2700 | 0.510 |
Why?
| Oxidation-Reduction | 8 | 2024 | 1013 | 0.510 |
Why?
| Blood Glucose Self-Monitoring | 1 | 2021 | 596 | 0.510 |
Why?
| Drug Administration Schedule | 4 | 2021 | 760 | 0.500 |
Why?
| Developmental Disabilities | 2 | 2015 | 254 | 0.500 |
Why?
| Sweetening Agents | 1 | 2015 | 38 | 0.500 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2016 | 528 | 0.490 |
Why?
| Infant, Small for Gestational Age | 2 | 2018 | 83 | 0.490 |
Why?
| Lactic Acid | 8 | 2024 | 296 | 0.480 |
Why?
| Postpartum Period | 1 | 2018 | 332 | 0.480 |
Why?
| Diazoxide | 3 | 2024 | 25 | 0.480 |
Why?
| Humans | 45 | 2024 | 128896 | 0.470 |
Why?
| Disease Models, Animal | 15 | 2024 | 3994 | 0.460 |
Why?
| Acidosis | 2 | 2020 | 88 | 0.450 |
Why?
| Uterus | 5 | 2022 | 204 | 0.450 |
Why?
| Pregnancy Complications | 3 | 2019 | 487 | 0.450 |
Why?
| Placental Circulation | 3 | 2021 | 63 | 0.440 |
Why?
| Endothelial Cells | 3 | 2018 | 734 | 0.440 |
Why?
| Stress, Physiological | 1 | 2016 | 412 | 0.410 |
Why?
| Hepatocytes | 5 | 2024 | 215 | 0.400 |
Why?
| Periodicals as Topic | 2 | 2017 | 209 | 0.400 |
Why?
| Glucose Clamp Technique | 5 | 2020 | 195 | 0.400 |
Why?
| Organ Size | 7 | 2021 | 446 | 0.400 |
Why?
| Random Allocation | 7 | 2012 | 351 | 0.390 |
Why?
| Muscle Development | 3 | 2021 | 103 | 0.380 |
Why?
| Malnutrition | 1 | 2012 | 78 | 0.380 |
Why?
| Male | 27 | 2024 | 63146 | 0.360 |
Why?
| Diabetes Mellitus, Type 2 | 6 | 2024 | 2421 | 0.360 |
Why?
| Dietary Supplements | 3 | 2012 | 533 | 0.340 |
Why?
| Pulmonary Artery | 2 | 2018 | 1091 | 0.340 |
Why?
| Insulins | 2 | 2022 | 36 | 0.330 |
Why?
| Dietary Proteins | 1 | 2011 | 131 | 0.330 |
Why?
| Insulin Resistance | 7 | 2019 | 1163 | 0.320 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.320 |
Why?
| Pulmonary Alveoli | 1 | 2011 | 403 | 0.310 |
Why?
| Infant | 9 | 2023 | 8994 | 0.300 |
Why?
| Fetal Diseases | 3 | 2021 | 148 | 0.300 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 138 | 0.290 |
Why?
| Muscle Fibers, Skeletal | 2 | 2021 | 187 | 0.290 |
Why?
| Gene Expression Regulation | 6 | 2021 | 2520 | 0.280 |
Why?
| Infusion Pumps | 2 | 2021 | 31 | 0.270 |
Why?
| Down-Regulation | 3 | 2017 | 637 | 0.260 |
Why?
| Fetal Macrosomia | 2 | 2021 | 60 | 0.260 |
Why?
| Amino Acids, Essential | 1 | 2006 | 12 | 0.260 |
Why?
| Up-Regulation | 4 | 2017 | 848 | 0.260 |
Why?
| History, 20th Century | 3 | 2017 | 294 | 0.250 |
Why?
| Glucose-6-Phosphatase | 4 | 2016 | 31 | 0.250 |
Why?
| Infusions, Intravenous | 5 | 2024 | 395 | 0.250 |
Why?
| Sheep, Domestic | 6 | 2019 | 34 | 0.240 |
Why?
| Breast Feeding | 2 | 2019 | 423 | 0.240 |
Why?
| Receptors, Glucagon | 1 | 2025 | 27 | 0.240 |
Why?
| Pediatrics | 5 | 2018 | 1060 | 0.230 |
Why?
| Prenatal Exposure Delayed Effects | 3 | 2024 | 544 | 0.230 |
Why?
| Neonatologists | 1 | 2024 | 6 | 0.230 |
Why?
| Fetal Heart | 1 | 2024 | 53 | 0.220 |
Why?
| Mitochondria, Heart | 1 | 2024 | 93 | 0.220 |
Why?
| Lipid Metabolism | 3 | 2024 | 491 | 0.210 |
Why?
| Adaptation, Physiological | 2 | 2021 | 516 | 0.210 |
Why?
| Arginine | 4 | 2012 | 254 | 0.210 |
Why?
| Chronic Disease | 4 | 2017 | 1715 | 0.210 |
Why?
| Norepinephrine | 4 | 2020 | 218 | 0.210 |
Why?
| Nervous System Diseases | 1 | 2006 | 260 | 0.210 |
Why?
| Hydrocortisone | 5 | 2020 | 300 | 0.210 |
Why?
| Carbohydrates | 1 | 2022 | 62 | 0.200 |
Why?
| Insulin-Like Growth Factor II | 2 | 2020 | 25 | 0.200 |
Why?
| Fetal Weight | 3 | 2022 | 56 | 0.190 |
Why?
| Diet, High-Fat | 2 | 2023 | 240 | 0.190 |
Why?
| Glycogen | 3 | 2020 | 55 | 0.190 |
Why?
| Myoblasts, Skeletal | 1 | 2021 | 12 | 0.190 |
Why?
| Feces | 1 | 2024 | 430 | 0.190 |
Why?
| Oxygen Consumption | 2 | 2024 | 676 | 0.190 |
Why?
| Insulinoma | 1 | 2021 | 30 | 0.180 |
Why?
| Chemokine CXCL10 | 1 | 2021 | 33 | 0.180 |
Why?
| Carotid Arteries | 2 | 2013 | 207 | 0.180 |
Why?
| I-kappa B Kinase | 1 | 2021 | 53 | 0.180 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2021 | 172 | 0.180 |
Why?
| Pancreatic Diseases | 1 | 2021 | 67 | 0.180 |
Why?
| Biosensing Techniques | 2 | 2014 | 115 | 0.180 |
Why?
| Endotoxemia | 1 | 2021 | 95 | 0.170 |
Why?
| Gene Silencing | 1 | 2021 | 180 | 0.170 |
Why?
| Transcriptome | 2 | 2024 | 871 | 0.170 |
Why?
| Mitochondria, Liver | 1 | 2020 | 73 | 0.170 |
Why?
| Chorioamnionitis | 1 | 2020 | 38 | 0.170 |
Why?
| Energy Intake | 1 | 2022 | 453 | 0.170 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2021 | 170 | 0.170 |
Why?
| Drug Synergism | 1 | 2020 | 354 | 0.170 |
Why?
| Receptor, Insulin | 2 | 2011 | 99 | 0.160 |
Why?
| Transcription Factors | 1 | 2007 | 1634 | 0.160 |
Why?
| Extracellular Matrix | 2 | 2013 | 493 | 0.160 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2019 | 168 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 957 | 0.150 |
Why?
| Phosphorylation | 3 | 2019 | 1685 | 0.150 |
Why?
| NF-kappa B p50 Subunit | 1 | 2018 | 22 | 0.150 |
Why?
| Cell Survival | 1 | 2021 | 1082 | 0.140 |
Why?
| Neonatology | 1 | 2018 | 22 | 0.140 |
Why?
| Transcription Factor RelA | 1 | 2018 | 85 | 0.140 |
Why?
| Vascular Stiffness | 2 | 2013 | 479 | 0.140 |
Why?
| Adipose Tissue | 1 | 2021 | 588 | 0.140 |
Why?
| Umbilical Cord | 2 | 2016 | 84 | 0.140 |
Why?
| Cell Count | 1 | 2018 | 316 | 0.140 |
Why?
| Infant, Extremely Premature | 1 | 2018 | 60 | 0.140 |
Why?
| Overnutrition | 1 | 2017 | 30 | 0.140 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2024 | 816 | 0.140 |
Why?
| Enteral Nutrition | 1 | 2019 | 186 | 0.140 |
Why?
| Infant Formula | 1 | 2017 | 75 | 0.140 |
Why?
| Gastrointestinal Microbiome | 1 | 2024 | 635 | 0.140 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 418 | 0.140 |
Why?
| Energy Metabolism | 2 | 2021 | 837 | 0.130 |
Why?
| Time Factors | 4 | 2012 | 6568 | 0.130 |
Why?
| Arteries | 1 | 2018 | 268 | 0.130 |
Why?
| Hemodynamics | 1 | 2021 | 1095 | 0.130 |
Why?
| Calcium | 1 | 2022 | 1173 | 0.130 |
Why?
| Potassium Chloride | 2 | 2014 | 34 | 0.130 |
Why?
| Blotting, Western | 4 | 2019 | 1188 | 0.130 |
Why?
| Ultrasonography, Prenatal | 1 | 2018 | 266 | 0.130 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2021 | 1204 | 0.130 |
Why?
| Treatment Failure | 1 | 2017 | 345 | 0.130 |
Why?
| Linear Models | 1 | 2018 | 817 | 0.120 |
Why?
| Lower Extremity | 1 | 2019 | 404 | 0.120 |
Why?
| Biomedical Research | 1 | 2022 | 654 | 0.120 |
Why?
| Amino Acids, Branched-Chain | 2 | 2012 | 33 | 0.120 |
Why?
| Practice Patterns, Physicians' | 1 | 2024 | 1281 | 0.120 |
Why?
| Cell Division | 1 | 2017 | 800 | 0.120 |
Why?
| Parenteral Nutrition | 1 | 2016 | 108 | 0.120 |
Why?
| Endocrine System Diseases | 1 | 2014 | 32 | 0.120 |
Why?
| Nurseries, Hospital | 1 | 2014 | 5 | 0.120 |
Why?
| Mice, Knockout | 1 | 2021 | 2770 | 0.110 |
Why?
| Hydrochlorothiazide | 1 | 2014 | 8 | 0.110 |
Why?
| Endocrinology | 1 | 2015 | 73 | 0.110 |
Why?
| Homeostasis | 1 | 2018 | 604 | 0.110 |
Why?
| Mice, Inbred C57BL | 1 | 2024 | 5270 | 0.110 |
Why?
| In Vitro Techniques | 1 | 2016 | 1061 | 0.110 |
Why?
| Aorta, Abdominal | 1 | 2013 | 42 | 0.110 |
Why?
| Cell Line, Tumor | 1 | 2021 | 3100 | 0.110 |
Why?
| Diuretics | 1 | 2014 | 74 | 0.110 |
Why?
| Glucose Transporter Type 3 | 2 | 2024 | 13 | 0.110 |
Why?
| Mice | 5 | 2024 | 16543 | 0.110 |
Why?
| Animals, Inbred Strains | 1 | 2012 | 7 | 0.100 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2018 | 383 | 0.100 |
Why?
| Pregnancy, Animal | 2 | 2019 | 53 | 0.100 |
Why?
| Pyruvic Acid | 2 | 2024 | 52 | 0.100 |
Why?
| Adrenal Cortex Hormones | 1 | 2016 | 525 | 0.100 |
Why?
| Cell Size | 1 | 2012 | 86 | 0.100 |
Why?
| Electrolytes | 1 | 2012 | 57 | 0.100 |
Why?
| Macrophages | 1 | 2020 | 1452 | 0.100 |
Why?
| Premature Birth | 1 | 2016 | 313 | 0.100 |
Why?
| Fibroblast Growth Factor 7 | 1 | 2012 | 16 | 0.100 |
Why?
| Solutions | 1 | 2012 | 147 | 0.100 |
Why?
| Umbilical Arteries | 1 | 2012 | 49 | 0.100 |
Why?
| Hyperplasia | 1 | 2012 | 171 | 0.100 |
Why?
| Vasodilator Agents | 1 | 2014 | 325 | 0.100 |
Why?
| Hernia, Diaphragmatic | 1 | 2012 | 69 | 0.100 |
Why?
| Heart | 1 | 2016 | 650 | 0.100 |
Why?
| AMP-Activated Protein Kinases | 2 | 2023 | 187 | 0.100 |
Why?
| Cell Aggregation | 1 | 2011 | 25 | 0.100 |
Why?
| Intestinal Obstruction | 1 | 2012 | 48 | 0.100 |
Why?
| Models, Cardiovascular | 1 | 2013 | 193 | 0.090 |
Why?
| Surveys and Questionnaires | 1 | 2024 | 5355 | 0.090 |
Why?
| Mitosis | 1 | 2012 | 177 | 0.090 |
Why?
| Infant Nutrition Disorders | 1 | 2011 | 11 | 0.090 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 86 | 0.090 |
Why?
| Parenteral Nutrition, Total | 1 | 2011 | 27 | 0.090 |
Why?
| Aorta, Thoracic | 1 | 2013 | 260 | 0.090 |
Why?
| Mammals | 2 | 2023 | 267 | 0.090 |
Why?
| Primary Cell Culture | 1 | 2011 | 159 | 0.090 |
Why?
| Animals, Newborn | 2 | 2024 | 813 | 0.090 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2011 | 204 | 0.090 |
Why?
| Taurine | 1 | 2011 | 41 | 0.090 |
Why?
| Carbon Dioxide | 2 | 2012 | 261 | 0.090 |
Why?
| Cell Hypoxia | 1 | 2011 | 238 | 0.090 |
Why?
| Algorithms | 3 | 2018 | 1626 | 0.090 |
Why?
| Intensive Care, Neonatal | 1 | 2010 | 41 | 0.080 |
Why?
| Blood Vessels | 1 | 2011 | 184 | 0.080 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2011 | 140 | 0.080 |
Why?
| Inflammation | 1 | 2020 | 2694 | 0.080 |
Why?
| Prevalence | 1 | 2016 | 2540 | 0.080 |
Why?
| Infusions, Parenteral | 1 | 2009 | 39 | 0.080 |
Why?
| Glycine | 2 | 2023 | 162 | 0.080 |
Why?
| Gene Expression | 2 | 2011 | 1476 | 0.080 |
Why?
| Apoptosis | 2 | 2019 | 2481 | 0.080 |
Why?
| Guidelines as Topic | 1 | 2010 | 259 | 0.070 |
Why?
| Liver Glycogen | 1 | 2007 | 17 | 0.070 |
Why?
| Oncogene Protein v-akt | 1 | 2007 | 26 | 0.070 |
Why?
| Cohort Studies | 1 | 2018 | 5394 | 0.070 |
Why?
| Insulin-Like Growth Factor Binding Protein 2 | 2 | 2020 | 9 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 1 | 2009 | 542 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2012 | 1694 | 0.070 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 5032 | 0.070 |
Why?
| Cell Movement | 1 | 2011 | 932 | 0.070 |
Why?
| Biological Transport | 2 | 2020 | 394 | 0.070 |
Why?
| Cloning, Molecular | 1 | 2007 | 536 | 0.070 |
Why?
| Lysine | 1 | 2009 | 266 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2007 | 417 | 0.070 |
Why?
| Proteins | 1 | 2012 | 945 | 0.060 |
Why?
| Nitric Oxide | 1 | 2011 | 892 | 0.060 |
Why?
| Lipopolysaccharides | 2 | 2020 | 877 | 0.060 |
Why?
| Gene Expression Profiling | 2 | 2024 | 1694 | 0.060 |
Why?
| Adult | 3 | 2023 | 35361 | 0.060 |
Why?
| Citrate (si)-Synthase | 1 | 2024 | 58 | 0.060 |
Why?
| Cell Respiration | 1 | 2024 | 92 | 0.060 |
Why?
| Embryo, Mammalian | 2 | 2019 | 223 | 0.060 |
Why?
| Risk Factors | 2 | 2016 | 9792 | 0.060 |
Why?
| Societies, Medical | 2 | 2020 | 760 | 0.050 |
Why?
| Cells, Cultured | 1 | 2011 | 4048 | 0.050 |
Why?
| Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| Oxidative Phosphorylation | 1 | 2024 | 184 | 0.050 |
Why?
| Elastin | 2 | 2013 | 78 | 0.050 |
Why?
| Glycosaminoglycans | 2 | 2013 | 85 | 0.050 |
Why?
| Glutamine | 1 | 2023 | 94 | 0.050 |
Why?
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2022 | 5 | 0.050 |
Why?
| Ruminants | 1 | 2022 | 7 | 0.050 |
Why?
| Serine | 1 | 2023 | 133 | 0.050 |
Why?
| Glucose Transporter Type 1 | 1 | 2022 | 48 | 0.050 |
Why?
| Calcium, Dietary | 1 | 2022 | 55 | 0.050 |
Why?
| Birth Weight | 2 | 2018 | 493 | 0.050 |
Why?
| Blastocyst | 1 | 2021 | 47 | 0.050 |
Why?
| Phosphates | 1 | 2022 | 168 | 0.050 |
Why?
| Treatment Outcome | 2 | 2017 | 10239 | 0.050 |
Why?
| Spinal Cord Neoplasms | 1 | 2001 | 39 | 0.050 |
Why?
| Placentation | 1 | 2021 | 44 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 39 | 0.040 |
Why?
| Collagen | 2 | 2013 | 433 | 0.040 |
Why?
| Ultrasonography, Doppler | 1 | 2021 | 118 | 0.040 |
Why?
| Astrocytoma | 1 | 2001 | 120 | 0.040 |
Why?
| Research Personnel | 1 | 2022 | 161 | 0.040 |
Why?
| Mentors | 1 | 2022 | 174 | 0.040 |
Why?
| Bromodeoxyuridine | 1 | 2019 | 77 | 0.040 |
Why?
| Weight Gain | 1 | 2023 | 504 | 0.040 |
Why?
| Amino Acid Transport Systems | 1 | 2020 | 40 | 0.040 |
Why?
| Glycolysis | 1 | 2021 | 295 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 2 | 2017 | 1968 | 0.040 |
Why?
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 21 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2021 | 575 | 0.040 |
Why?
| Adenosine Triphosphatases | 1 | 2020 | 164 | 0.040 |
Why?
| Sodium | 1 | 2020 | 203 | 0.040 |
Why?
| Blood Flow Velocity | 1 | 2020 | 413 | 0.040 |
Why?
| Alanine | 1 | 2019 | 134 | 0.040 |
Why?
| Vitamin D | 1 | 2022 | 384 | 0.040 |
Why?
| Lung | 1 | 2011 | 3925 | 0.040 |
Why?
| Body Weight | 2 | 2012 | 931 | 0.040 |
Why?
| Fatal Outcome | 2 | 2012 | 301 | 0.030 |
Why?
| Temperature | 1 | 2019 | 634 | 0.030 |
Why?
| Delphi Technique | 1 | 2018 | 219 | 0.030 |
Why?
| Term Birth | 1 | 2016 | 20 | 0.030 |
Why?
| Regional Blood Flow | 2 | 2008 | 462 | 0.030 |
Why?
| Lactates | 1 | 2015 | 83 | 0.030 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2016 | 105 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 2014 | 35 | 0.030 |
Why?
| Consensus | 1 | 2018 | 644 | 0.030 |
Why?
| Models, Animal | 1 | 2016 | 370 | 0.030 |
Why?
| Immunity, Innate | 1 | 2020 | 802 | 0.030 |
Why?
| Blood Transfusion | 1 | 2016 | 294 | 0.030 |
Why?
| Glutamic Acid | 1 | 2014 | 227 | 0.030 |
Why?
| Compliance | 1 | 2012 | 50 | 0.030 |
Why?
| Lymphocyte Count | 1 | 2012 | 149 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 24 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 29 | 0.020 |
Why?
| Acid-Base Equilibrium | 1 | 2012 | 27 | 0.020 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 159 | 0.020 |
Why?
| Blood Gas Analysis | 1 | 2012 | 71 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2012 | 392 | 0.020 |
Why?
| Pulmonary Gas Exchange | 1 | 2012 | 119 | 0.020 |
Why?
| Carbon Isotopes | 1 | 2012 | 121 | 0.020 |
Why?
| Proteolysis | 1 | 2012 | 162 | 0.020 |
Why?
| Tissue Distribution | 1 | 2012 | 295 | 0.020 |
Why?
| Forkhead Transcription Factors | 1 | 2012 | 182 | 0.020 |
Why?
| Hormones | 1 | 2012 | 139 | 0.020 |
Why?
| Stimulation, Chemical | 1 | 2011 | 62 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2012 | 404 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 326 | 0.020 |
Why?
| Diseases in Twins | 1 | 2012 | 174 | 0.020 |
Why?
| Erythrocytes | 1 | 2016 | 667 | 0.020 |
Why?
| Death, Sudden, Cardiac | 1 | 2012 | 179 | 0.020 |
Why?
| Myocardium | 1 | 2016 | 981 | 0.020 |
Why?
| Trans-Activators | 1 | 2012 | 387 | 0.020 |
Why?
| Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2012 | 204 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 2009 | 42 | 0.020 |
Why?
| Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.020 |
Why?
| Eukaryotic Initiation Factor-4E | 1 | 2008 | 26 | 0.020 |
Why?
| Somatostatin | 1 | 2008 | 55 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 480 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1619 | 0.020 |
Why?
| Respiratory Insufficiency | 1 | 2012 | 316 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2016 | 1523 | 0.020 |
Why?
| Remission Induction | 1 | 2009 | 269 | 0.020 |
Why?
| Child | 2 | 2020 | 20824 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 154 | 0.020 |
Why?
| Glucose Transport Proteins, Facilitative | 1 | 2007 | 12 | 0.020 |
Why?
| Biomarkers | 1 | 2019 | 3874 | 0.020 |
Why?
| Protein Kinases | 1 | 2008 | 305 | 0.020 |
Why?
| Sex Characteristics | 1 | 2011 | 722 | 0.020 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2008 | 379 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 1743 | 0.020 |
Why?
| Body Temperature | 1 | 2005 | 215 | 0.010 |
Why?
| United States | 1 | 2022 | 13975 | 0.010 |
Why?
| Hypertension | 1 | 2012 | 1236 | 0.010 |
Why?
| Models, Biological | 1 | 2009 | 1702 | 0.010 |
Why?
| Rats | 1 | 2010 | 5236 | 0.010 |
Why?
| Laminectomy | 1 | 2001 | 27 | 0.010 |
Why?
| Thoracic Vertebrae | 1 | 2001 | 72 | 0.010 |
Why?
| Child, Preschool | 1 | 2015 | 10457 | 0.010 |
Why?
| Obesity | 1 | 2011 | 2844 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2001 | 3348 | 0.000 |
Why?
|
|
Rozance's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|